Adia Nutrition (ADIA) Total Liabilities (2024 - 2026)
Adia Nutrition's (ADIA) quarterly Total Liabilities came in at $1.2 million in Q1 2026, up 1220.11% year-over-year from $90679.0 in Q1 2025, and up 40.42% quarter-over-quarter from $852500.0 in Q4 2025.
Analysis
Adia Nutrition (ADIA) Total Liabilities (2024 - 2026) Analysis & Trends
Adia Nutrition (ADIA) has reported Total Liabilities for 3 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- On a quarterly basis, Total Liabilities rose 1220.11% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 1220.11% increase from a year earlier, with the FY2025 full-year figure at $852500.0, up 33.07% from the prior year.
- Total Liabilities was $1.2 million for Q1 2026 at Adia Nutrition, up from $852500.0 in the prior quarter.
- Over five years, Total Liabilities peaked at $1.2 million in Q1 2026 and troughed at $90679.0 in Q1 2025.
- A 3-year average of $695221.8 and a median of $746570.5 in 2024 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities surged 33.07% in 2025 and surged 1220.11% in 2026, its largest moves.
- Over 3 years, Total Liabilities stood at $640641.0 in 2024, then soared by 33.07% to $852500.0 in 2025, then surged by 40.42% to $1.2 million in 2026.
- The last three Total Liabilities figures came in at $1.2 million (Q1 2026), $852500.0 (Q4 2025), and $90679.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 9.96 Bn | 9.12 Bn | 112.79 Mn | 141.52 Mn |
| 2 | CRISPR Therapeutics AG | 5.47 Bn | 5.47 Bn | - | 904.22 Mn |
| 3 | Iovance Biotherapeutics | 4.64 Bn | 4.35 Bn | 55.72 Mn | 179.49 Mn |
| 4 | Legend Biotech | 3.25 Bn | 2.28 Bn | 251.50 Mn | 521.30 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 661.05 Mn |
| 6 | Precigen | 2.79 Bn | 2.79 Bn | 52.17 Mn | 126.72 Mn |
| 7 | Beam Therapeutics | 2.58 Bn | 2.58 Bn | - | 318.91 Mn |
| 8 | Sarepta Therapeutics | 2.12 Bn | 1.33 Bn | 251.87 Mn | 1.66 Bn |
| 9 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | 132.83 Mn |
| 10 | Adia Nutrition | 11.33 Mn | 11.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 852,500.00 |
| Mar 31, 2025 | 90,679.00 |
| Dec 31, 2024 | 640,641.00 |